Michael Y. Choi, MD | Authors

1200 6TH AVE N


How Do Targeted Therapies Change the Management of Indolent Lymphomas?

September 15, 2016

Prior to the advent of targeted therapies, there were few options other than chemotherapy for the treatment of patients with indolent B-cell lymphomas or chronic lymphocytic leukemia.